The data are expressed in fold-changes in the phosphopeptides amounts in the phosphocofilin spot (control/pyr-1 treated). These fold-changes are obtained by the proper combination of the normalized phosphopeptide abundance described in S2–S5 Tables with the spot abundances changes described in Table 3.</p
<p>Volcano plot of the phosphoproteomic data of cells treated with an Plk1 tyrosine kinase inhibitor...
<p>Listed above is a portion of the data collected, representing proteins not previously established...
<p>Volcano plots showing −log<sub>10</sub> P-values in relation to log<sub>2</sub> T/NT ratios for; ...
<p>List of phosphopeptides that show significant changes in abundance in response to CSPG treatment ...
To reduce the spot crowding around the phosphocofilin spot, a linear 4–8 pH gradient was used. This ...
The data for spot I abundance are expressed in percentage of the sum of all spots measured on the si...
<p>(<b>A</b>) Volcano plot visualising quantified phospho-sites with significant differences between...
<p>List of the proteins that showed significantly (p <0.05) altered abundance in LPS and LPS+INU sam...
<p>Phosphopeptides shown are a selection where a confident assessment of a common decrease or increa...
<p>Changes in phosphorylation abundance are represented as heatmaps from 5 replicate experiments as ...
<p>Changes in accumulation of LCBs and phospho-LCBs in response to SphK expression and SphK inhibiti...
<p>Phosphorylation of HSL and PLIN by PKA was detected in the presence or absence (0 min) of 1 mg/ml...
<p>Here are examples of phosphopeptides that contain activator and inhibitor phosphorylation sites o...
<p>Listed above is a portion of the data collected, representing proteins not previously established...
Phosphopeptide enrichment was performed with a pooled MM digest using 12.5 to 200 ug of input materi...
<p>Volcano plot of the phosphoproteomic data of cells treated with an Plk1 tyrosine kinase inhibitor...
<p>Listed above is a portion of the data collected, representing proteins not previously established...
<p>Volcano plots showing −log<sub>10</sub> P-values in relation to log<sub>2</sub> T/NT ratios for; ...
<p>List of phosphopeptides that show significant changes in abundance in response to CSPG treatment ...
To reduce the spot crowding around the phosphocofilin spot, a linear 4–8 pH gradient was used. This ...
The data for spot I abundance are expressed in percentage of the sum of all spots measured on the si...
<p>(<b>A</b>) Volcano plot visualising quantified phospho-sites with significant differences between...
<p>List of the proteins that showed significantly (p <0.05) altered abundance in LPS and LPS+INU sam...
<p>Phosphopeptides shown are a selection where a confident assessment of a common decrease or increa...
<p>Changes in phosphorylation abundance are represented as heatmaps from 5 replicate experiments as ...
<p>Changes in accumulation of LCBs and phospho-LCBs in response to SphK expression and SphK inhibiti...
<p>Phosphorylation of HSL and PLIN by PKA was detected in the presence or absence (0 min) of 1 mg/ml...
<p>Here are examples of phosphopeptides that contain activator and inhibitor phosphorylation sites o...
<p>Listed above is a portion of the data collected, representing proteins not previously established...
Phosphopeptide enrichment was performed with a pooled MM digest using 12.5 to 200 ug of input materi...
<p>Volcano plot of the phosphoproteomic data of cells treated with an Plk1 tyrosine kinase inhibitor...
<p>Listed above is a portion of the data collected, representing proteins not previously established...
<p>Volcano plots showing −log<sub>10</sub> P-values in relation to log<sub>2</sub> T/NT ratios for; ...